Which model incorporates an evaluation for genetic mutations in breast cancer risk assessment?

Which model incorporates an evaluation for genetic mutations in breast cancer risk assessment?

• A. Gail model
• B. Ford model
• C. Claus model
• D. SEER model

Answer: (B)

The Ford model is particularly significant because it includes an assessment of genetic mutations, specifically BRCA1 and BRCA2, which are strongly associated with an increased risk of breast cancer. This model is designed to help identify individuals who may be at higher risk due to hereditary factors, allowing for more tailored screening and preventive measures. In contrast, other models like the Gail model focus primarily on personal and family history of breast cancer, but do not directly evaluate genetic mutations. The Claus model similarly assesses family history but does not specifically incorporate genetic testing. The SEER model is a statistical system for cancer incidence and survival and does not serve as a risk assessment model for individual patients regarding genetic mutations. Therefore, the Ford model stands out for its inclusion of genetic evaluation, making it a crucial tool in genetic risk assessment for breast cancer.

The Ford model is particularly significant because it includes an assessment of genetic mutations, specifically BRCA1 and BRCA2, which are strongly associated with an increased risk of breast cancer. This model is designed to help identify individuals who may be at higher risk due to hereditary factors, allowing for more tailored screening and preventive measures.

In contrast, other models like the Gail model focus primarily on personal and family history of breast cancer, but do not directly evaluate genetic mutations. The Claus model similarly assesses family history but does not specifically incorporate genetic testing. The SEER model is a statistical system for cancer incidence and survival and does not serve as a risk assessment model for individual patients regarding genetic mutations. Therefore, the Ford model stands out for its inclusion of genetic evaluation, making it a crucial tool in genetic risk assessment for breast cancer.